Porton Advanced

Porton Advanced offers CDMO services for personalized pDNA/RNA LNP cancer vaccines, including plasmid DNA production, RNA synthesis (mRNA/saRNA/circRNA), LNP formulation, cGMP drug product manufacturing, fill/finish, and global clinical supply. Our integrated platform enables fast delivery from plasmid production to final mRNA-LNP DP release within 6–8 weeks. We currently have 70+ PCV projects with clients across the US, China, and EU. More than 40 of these are U.S. spIND mRNA-LNP programs, with 6 patients dosed to date.
www.portonadvanced.com

Porton primary logo transparent
Porton primary logo transparent